TGF/BMP signalling and Pulmonary Hypertension

Dr Mark Toshner answers the question; will Sotatercept be the first drug to treat the common forms of pulmonary hypertension?

Tuesday 2 June, 7pm - 8pm

This insightful and educational session is part of the RESP (Respiratory Expert Speaker and Patient) webinar series, proudly presented by Respiratory Futures, INSPIRE and Asthma + Lung UK.

This webinar features expert speaker Dr Mark Toshner.

This session will cover

• Management of Pulmonary Hypertension for the non-specialist
• Novel treatment options
• Expert patient insights

Meet the speaker

Mark leads a translational research programme focused on therapy development in cardiorespiratory disease leveraging novel adaptive methods and technology enabled clinical trials. He is the Director of the VPD HLRI Clinical Research Facility in Cambridge and the Director of the UniPHy national trials network in pulmonary hypertension.

Sign up for the free webinar